Facing hostility from nearly every corner of Capitol Hill, drug makers have spent recent weeks aggressively courting a group of business-friendly Democrats. PhRMA and BIO, the two major drug industry trade groups, met last week with the New Democrat Coalition, according to multiple Democratic aides.